Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00701350 · ClinicalTrials.gov registry record

Biomarkers of Intra-amniotic Infection in Women With Preterm Premature Ruptured Amniotic Membranes

A clinical trial of Preterm Birth and Intra-amniotic Infection, sponsored by ProteoGenix.

Completed
Registry status
79
Enrollment target
4
Study locations

NCT00701350 is a study of Preterm Birth and Intra-amniotic Infection that has completed, run by ProteoGenix. The registered enrollment target is 79 participants, below the 4,628-participant average among 37 other Preterm Birth trials with a reported enrollment target (98% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00701350, a study of Preterm Birth and Intra-amniotic Infection, has completed, sponsored by ProteoGenix.

COMPLETED
Registry status
79 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to investigate the expression of protein biomarkers in cervical vaginal fluid in women with preterm premature rupture of membranes (PPROM)

Conditions Studied

Preterm Birth Intra-amniotic Infection

Study Locations (4)

Arizona

  • Banner Good Samaritan Hospital - Phoenix
  • Tucson Medical Center - Tucson

California

  • Good Samaritan Hospital - San Jose

Colorado

  • Presbyterian St. Luke's Medical Center - Denver

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2008-06
Est. Completion 2010-02

Sponsor

ProteoGenix

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00701350

The ClinicalTrials.gov registry entry for NCT00701350 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,628-participant average among 37 other Preterm Birth trials with a reported enrollment target (98% lower). The listed sponsor is ProteoGenix, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Preterm Birth appearing as the primary indexed condition, and to 0 interventions.

NCT00701350 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Arizona, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT00701350 about?

NCT00701350 is a clinical study titled "Biomarkers of Intra-amniotic Infection in Women With Preterm Premature Ruptured Amniotic Membranes". The purpose of this study is to investigate the expression of protein biomarkers in cervical vaginal fluid in women with preterm premature rupture of membranes (PPROM)

What is the current status of trial NCT00701350?

This trial is currently completed. The enrollment target is 79 participants. The study started on 2008-06. Estimated completion is 2010-02.

What conditions does trial NCT00701350 study?

This clinical trial studies the following conditions: Preterm Birth, Intra-amniotic Infection.

Who is sponsoring clinical trial NCT00701350?

This trial is sponsored by ProteoGenix, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00701350 being conducted?

This trial has 4 study locations across Arizona, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Preterm Birth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Preterm Birth

All registered trials for this condition

Intra-amniotic Infection

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.